RPRX icon

Royalty Pharma

324 hedge funds and large institutions have $9.31B invested in Royalty Pharma in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 139 increasing their positions, 106 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

12% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 51

14% less capital invested

Capital invested by funds: $10.9B → $9.31B (-$1.56B)

20% less funds holding in top 10

Funds holding in top 10: 108 (-2)

Holders
324
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$21.9M
Puts
$5.29M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
151
$1.76M
152
$1.74M
153
$1.71M
154
$1.66M
155
$1.65M
156
$1.57M
157
$1.54M
158
$1.52M
159
$1.48M
160
$1.45M
161
$1.45M
162
$1.44M
163
$1.42M
164
$1.39M
165
$1.37M
166
$1.35M
167
$1.33M
168
$1.32M
169
$1.3M
170
$1.29M
171
$1.26M
172
$1.21M
173
$1.2M
174
$1.2M
175
$1.2M